Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Concern J&J may give Indian hip patients worse deal than US patients

This article was originally published in Scrip

Executive Summary

Johnson & Johnson has said it will cover the costs of testing and treating patients in India who had been implanted with the company’s faulty ASR hip devices. However, some experts believe that Indian patients may be getting a raw deal compared with US patients because they are less organized and because most are unaware of the complications the device could have posed. Many may also be unaware of the company's efforts to reach out to them, the experts emphasize.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts